The role of ArlRS in regulating oxacillin susceptibility in methicillin-resistant Staphylococcus aureus indicates it is a potential target for antimicrobial resistance breakers

References

• Tong SYC, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661. doi: 10.1128/cmr.00134-14
   PubMed Web of Science ®Google Scholar
• Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005;115:642–648. doi: 10.1542/peds.2004-2300
   PubMed Web of Science ®Google Scholar
• Roberts RB, Chung M, De Lencastre H, et al. Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey, and Pennsylvania. Microb Drug Resist. 2000;6:245–251. doi: 10.1089/mdr.2000.6.245
   PubMed Web of Science ®Google Scholar
• Otto M. Community-associated MRSA: what makes them special? Int J Med Microbiol. 2013;303:324–330. doi: 10.1016/j.ijmm.2013.02.007
   PubMed Web of Science ®Google Scholar
• Rybak MJ, Akins RL. Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance: clinical significance and treatment options. Drugs. 2001;61:1–7. doi: 10.2165/00003495-200161010-00001
   PubMed Web of Science ®Google Scholar
• Sakoulas G, Gold HS, Venkataraman L, et al. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J Clin Microbiol. 2001;39:3946–3951. doi: 10.1128/jcm.39.11.3946-3951.2001
   PubMed Web of Science ®Google Scholar
• Tesch W, Ryffel C, Strassle A, et al. Evidence of a novel staphylococcal mec-encoded element (mecR) controlling expression of penicillin-binding protein 2′. Antimicrob Agents Chemother. 1990;34:1703–1706. doi: 10.1128/AAC.34.9.1703
   PubMed Web of Science ®Google Scholar
• Ryffel C, Kayser FH, Berger-Bachi B. Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci. Antimicrob Agents Chemother. 1992;36:25–31. doi: 10.1128/AAC.36.1.25
   PubMed Web of Science ®Google Scholar
• Hackbarth CJ, Chambers HF. Blai and blaR1 regulate beta-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1993;37:1144–1149. doi: 10.1128/AAC.37.5.1144
   PubMed Web of Science ®Google Scholar
• Rosato AE, Kreiswirth BN, Craig WA, et al. mecA-blaZ corepressors in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother. 2003;47:1460–1463. doi: 10.1128/AAC.47.4.1460-1463.2003
   PubMed Web of Science ®Google Scholar
• Goldstein F, Perutka J, Cuirolo A, et al. Identification and phenotypic characterization of a beta-lactam-dependent, methicillin-resistant Staphylococcus aureus strain. Antimicrob Agents Chemother. 2007;51:2514–2522. doi: 10.1128/aac.00040-07
   PubMed Web of Science ®Google Scholar
• Stranden AM, Ehlert K, Labischinski H, et al. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J Bacteriol. 1997;179:9–16. doi: 10.1128/jb.179.1.9-16.1997
   PubMed Web of Science ®Google Scholar
• Piriz Duran S, Kayser FH, Berger-Bachi B. Impact of sar and agr on methicillin resistance in Staphylococcus aureus. FEMS Microbiol Lett. 1996;141:255–260. doi: 10.1111/j.1574-6968.1996.tb08394.x
   PubMed Web of Science ®Google Scholar
• Li L, Cheung A, Bayer AS, et al. The global regulon sarA regulates beta-lactam antibiotic resistance in methicillin-resistant Staphylococcus aureus In vitro and in endovascular infections. J Infect Dis. 2016;214:1421–1429. doi: 10.1093/infdis/jiw386
   PubMed Web of Science ®Google Scholar
• Singh VK, Schmidt JL, Jayaswal RK, et al. Impact of sigB mutation on Staphylococcus aureus oxacillin and vancomycin resistance varies with parental background and method of assessment. Int J Antimicrob Agents. 2003;21:256–261. doi: 10.1016/S0924-8579(02)00359-X
   PubMed Web of Science ®Google Scholar
• Memmi G, Nair DR, Cheung A. Role of ArlRS in autolysis in methicillin-sensitive and methicillin-resistant Staphylococcus aureus strains. J Bacteriol. 2012;194:759–767. doi: 10.1128/JB.06261-11
   PubMed Web of Science ®Google Scholar
• Ji Y, Yu C, Liang X. Transcriptomic analysis of ArlRS two-component signaling regulon, a global regulator, in Staphylococcus aureus. Methods Enzymol. 2007;423:502–513. DOI:S0076-6879(07)23024-1 [pii]. doi: 10.1016/S0076-6879(07)23024-1
   PubMed Web of Science ®Google Scholar
• Luong TT, Lee CY. The arl locus positively regulates Staphylococcus aureus type 5 capsule via an mgrA-dependent pathway. Microbiology. 2006;152:3123–3131. doi: 10.1099/mic.0.29177-0
   PubMed Web of Science ®Google Scholar
• Liang X, Zheng L, Landwehr C, et al. Global regulation of gene expression by ArlRS, a two-component signal transduction regulatory system of Staphylococcus aureus. J Bacteriol. 2005;187:5486–5492. DOI: 187/15/5486-a [pii]. DOI:10.1128/JB.187.15.5486-5492.2005
   PubMed Web of Science ®Google Scholar
• Fournier B, Klier A. Protein A gene expression is regulated by DNA supercoiling which is modified by the ArlS-ArlR two-component system of Staphylococcus aureus. Microbiology. 2004;150:3807–3819. doi: 10.1099/mic.0.27194-0
   PubMed Web of Science ®Google Scholar
• Fournier B, Hooper DC. A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus. J Bacteriol. 2000;182:3955–3964. doi: 10.1128/JB.182.14.3955-3964.2000
   PubMed Web of Science ®Google Scholar
• Fournier B, Klier A, Rapoport G. The two-component system ArlS-ArlR is a regulator of virulence gene expression in Staphylococcus aureus. Mol Microbiol. 2001;41:247–261. DOI:mmi2515 [pii]. doi: 10.1046/j.1365-2958.2001.02515.x
   PubMed Web of Science ®Google Scholar
• Burgui S, Gil C, Solano C, et al. A systematic evaluation of the two-component systems network reveals that ArlRS is a key regulator of catheter colonization by Staphylococcus aureus. Front Microbiol. 2018;9:342. doi: 10.3389/fmicb.2018.00342
   PubMed Web of Science ®Google Scholar
• Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006;367:731–739. doi: 10.1016/s0140-6736(06)68231-7
   PubMed Web of Science ®Google Scholar
• Charpentier E, Anton AI, Barry P, et al. Novel cassette-based shuttle vector system for gram-positive bacteria. Appl Environ Microbiol. 2004;70:6076–6085. doi: 10.1128/aem.70.10.6076-6085.2004
   PubMed Web of Science ®Google Scholar
• Xu T, Wu Y, Lin Z, et al. Identification of genes controlled by the essential YycFG two-component system reveals a role for biofilm modulation in Staphylococcus epidermidis. Front Microbiol. 2017;8:724, doi: 10.3389/fmicb.2017.00724
   PubMed Web of Science ®Google Scholar
• Bae T, Schneewind O. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid. 2006;55:58–63. doi: 10.1016/j.plasmid.2005.05.005
   PubMed Web of Science ®Google Scholar
• Pang YY, Schwartz J, Thoendel M, et al. agr-Dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J Innate Immun. 2010;2:546–559. doi: 10.1159/000319855
   PubMed Web of Science ®Google Scholar
• Dubendorff JW, Studier FW. Controlling basal expression in an inducible T7 expression system by blocking the target T7 promoter with lac repressor. J Mol Biol. 1991;219:45–59. doi: 10.1016/0022-2836(91)90856-2
   PubMed Web of Science ®Google Scholar
• Bruckner R. Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol Lett. 1997;151:1–8. DOI:S0378-1097(97)00116-X [pii]. doi: 10.1016/S0378-1097(97)00116-X
   PubMed Web of Science ®Google Scholar
• Vuong C, Gotz F, Otto M. Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect Immun. 2000;68:1048–1053. doi: 10.1128/IAI.68.3.1048-1053.2000
   PubMed Web of Science ®Google Scholar
• Martinez-Irujo JJ, Villahermosa ML, Alberdi E, et al. A checkerboard method to evaluate interactions between drugs. Biochem Pharmacol. 1996;51:635–644. doi: 10.1016/S0006-2952(95)02230-9
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Crosby HA, Schlievert PM, Merriman JA, et al. The Staphylococcus aureus global regulator MgrA modulates clumping and virulence by controlling surface protein expression. PLoS Pathog. 2016;12:e1005604. doi: 10.1371/journal.ppat.1005604
   PubMed Web of Science ®Google Scholar
• Sun F, Zhou L, Zhao B-C, et al. Targeting MgrA-mediated virulence regulation in Staphylococcus aureus. Chem Biol. 2011;18:1032–1041. doi: 10.1016/j.chembiol.2011.05.014
   PubMedGoogle Scholar
• Trotonda MP, Xiong YQ, Memmi G, et al. Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics. J Infect Dis. 2009;199:209–218. doi: 10.1086/595740
   PubMed Web of Science ®Google Scholar
• Villet RA, Truong-Bolduc QC, Wang Y, et al. Regulation of expression of abcA and its response to environmental conditions. J Bacteriol. 2014;196:1532–1539. doi: 10.1128/jb.01406-13
   PubMed Web of Science ®Google Scholar
• Truong-Bolduc QC, Hooper DC. The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus. J Bacteriol. 2007;189:2996–3005. doi: 10.1128/jb.01819-06
   PubMed Web of Science ®Google Scholar
• Komatsuzawa H, Ohta K, Sugai M, et al. Tn551-mediated insertional inactivation of the fmtB gene encoding a cell wall-associated protein abolishes methicillin resistance in Staphylococcus aureus. J Antimicrob Chemother. 2000;45:421–431. doi: 10.1093/jac/45.4.421
   PubMed Web of Science ®Google Scholar
• Zuber P. Spx-RNA polymerase interaction and global transcriptional control during oxidative stress. J Bacteriol. 2004;186:1911–1918. doi: 10.1128/JB.186.7.1911-1918.2004
   PubMed Web of Science ®Google Scholar
• Kajfasz JK, Mendoza JE, Gaca AO, et al. The Spx regulator modulates stress responses and virulence in Enterococcus faecalis. Infect Immun. 2012;80:2265–2275. doi: 10.1128/IAI.00026-12
   PubMed Web of Science ®Google Scholar
• Pamp SJ, Frees D, Engelmann S, et al. Spx is a global effector impacting stress tolerance and biofilm formation in Staphylococcus aureus. J Bacteriol. 2006;188:4861–4870. doi: 10.1128/JB.00194-06
   PubMed Web of Science ®Google Scholar
• Kajfasz JK, Rivera-Ramos I, Abranches J, et al. Two Spx proteins modulate stress tolerance, survival, and virulence in Streptococcus mutans. J Bacteriol. 2010;192:2546–2556. doi: 10.1128/JB.00028-10
   PubMed Web of Science ®Google Scholar
• Villanueva M, Jousselin A, Baek KT, et al. Rifampin resistance rpoB Alleles or multicopy thioredoxin/thioredoxin reductase suppresses the lethality of disruption of the global stress regulator spx in Staphylococcus aureus. J Bacteriol. 2016;198:2719–2731. doi: 10.1128/JB.00261-16
   PubMed Web of Science ®Google Scholar
• Jousselin A, Kelley WL, Barras C, et al. The Staphylococcus aureus thiol/oxidative stress global regulator Spx controls trfA, a gene implicated in cell wall antibiotic resistance. Antimicrob Agents Chemother. 2013;57:3283–3292. doi: 10.1128/AAC.00220-13
   PubMed Web of Science ®Google Scholar
• Renzoni A, Kelley WL, Barras C, et al. Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2009;53:903–911. doi: 10.1128/aac.01287-08
   PubMed Web of Science ®Google Scholar
• Gohring N, Fedtke I, Xia G, et al. New role of the disulfide stress effector YjbH in beta-lactam susceptibility of Staphylococcus aureus. Antimicrob Agents Chemother. 2011;55:5452–5458. doi: 10.1128/AAC.00286-11
   PubMed Web of Science ®Google Scholar
• Okada A, Gotoh Y, Watanabe T, et al. Targeting two-component signal transduction: a novel drug discovery system. Methods Enzymol. 2007;422:386–395. doi: 10.1016/S0076-6879(06)22019-6
   PubMed Web of Science ®Google Scholar
• Stephenson K, Hoch JA. Developing inhibitors to selectively target two-component and phosphorelay signal transduction systems of pathogenic microorganisms. Curr Med Chem. 2004;11:765–773. doi: 10.2174/0929867043455765
   PubMed Web of Science ®Google Scholar
• Stephenson K, Hoch JA. Two-component and phosphorelay signal-transduction systems as therapeutic targets. Curr Opin Pharmacol. 2002;2:507–512. DOI:S1471489202001947 [pii]. doi: 10.1016/S1471-4892(02)00194-7
   PubMed Web of Science ®Google Scholar
• Macielag MJ, Demers JP, Fraga-Spano SA, et al. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria. J Med Chem. 1998;41:2939–2945. doi: 10.1021/jm9803572
   PubMed Web of Science ®Google Scholar
• Liu H, Zhao D, Chang J, et al. Efficacy of novel antibacterial compounds targeting histidine kinase YycG protein. Appl Microbiol Biotechnol. 2014;98:6003–6013. doi: 10.1007/s00253-014-5685-8
   PubMed Web of Science ®Google Scholar
• Rasko DA, Moreira CG, Li D. R, et al. Targeting QseC signaling and virulence for antibiotic development. Science. 2008;321:1078–1080. doi: 10.1126/science.1160354
   PubMed Web of Science ®Google Scholar
• Gupta RK, Thakur TS, Desiraju GR, et al. Structure-based design of DevR inhibitor active against nonreplicating Mycobacterium tuberculosis. J Med Chem. 2009;52:6324–6334. doi: 10.1021/jm900358q
   PubMed Web of Science ®Google Scholar
• Bem AE, Velikova N, Pellicer MT, et al. Bacterial histidine kinases as novel antibacterial drug targets. ACS Chem Biol. 2015;10:213–224. doi: 10.1021/cb5007135
   PubMed Web of Science ®Google Scholar
• Zhanel GG, Schweizer F, Karlowsky JA. Oritavancin: mechanism of action. Clin Infect Dis. 2012;54(Suppl 3):S214–S219. doi: 10.1093/cid/cir920
   PubMed Web of Science ®Google Scholar
• Corey GR, Kabler H, Mehra P, et al. Single-dose oritavancin in the treatment of acute bacterial skin infections. N Engl J Med. 2014;370:2180–2190. doi: 10.1056/NEJMoa1310422
   PubMed Web of Science ®Google Scholar
• Belley A, Neesham-Grenon E, McKay G, et al. Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro. Antimicrob Agents Chemother. 2009;53:918–925. doi: 10.1128/AAC.00766-08
   PubMed Web of Science ®Google Scholar